News Release

Norepinephrine important in retrieving memories

Peer-Reviewed Publication

University of Pennsylvania School of Medicine

(Philadelphia, PA) - Researchers at the University of Pennsylvania School of Medicine have found that the neurotransmitter norepinephrine is essential in retrieving certain types of memories. This represents the first description of a molecule implicated in recalling memories as opposed to laying down new memories. Teasing apart different components of this pathway may help physicians better understand post-traumatic stress disorder (PTSD) and depression -- both of which involve alterations in memory retrieval, says lead author Steven A. Thomas, MD, PhD, Assistant Professor of Pharmacology. The findings of this research appear in the April 2 issue of Cell.

Using mutant mice lacking norepinephrine and rats treated with drugs that block some norepinephrine receptors (beta blockers), the research team found that this neurotransmitter is critical for retrieving intermediate-term contextual and spatial memories, but not for the formation or long-term consolidation of emotional memories, as previously hypothesized by others.

Mice and rats went through learning tasks that employ different brain regions: the hippocampus, which governs spatial and contextual memories; and the amygdala, which is important for emotional learning and memory in general.

The results of their tests ran counter to currently held hypotheses that suggest that stress hormones like norepinephrine are responsible for enhanced memory formation during emotionally arousing times. "Indeed, we set out to test that hypothesis with our norepinephrine-deficient mice," says Thomas. "We expected to see a difference in amygdala-dependent behaviors between the mutants and controls if it were emotional memory, in general, that was being affected by the absence of norepinephrine. But we didn't see that. Instead, we found a specific impairment in hippocampus-dependent contextual memory retrieval."

Using rats given beta blockers and a swimming navigation task in a water maze, which relies on the hippocampus but not the amygdala, the researchers sought to determine if norepinephrine was also necessary for spatial memories. The tests indicated that norepinephrine is critical for a period of time after a memory is formed, but is not critical in recalling older memories. "There are probably other mechanisms important for retrieving memories for the longer term that are independent of norepinephrine," says Thomas.

This line of research may have relevance to human learning and memory. Patients suffering from post-traumatic stress disorder have recurrent intrusive memories; that is, they experience traumatic events from the past in their minds. Evidence from studies in other labs suggests that in PTSD there might be hyper-signaling by norepinephrine. "Perhaps that's one reason why PTSD patients experience these recurrent intrusive memories," says Thomas.

Depression may include the opposite problem in that there's often difficulty in memory retrieval, and this could be due, in part, to dysfunction of the adrenergic system. In addition, beta-blockers, which are used to treat heart failure and hypertension (among other ailments) block the same norepinephrine receptors important for memory retrieval. Therefore, when treating heart disease, the use of beta blockers that do not cross into the brain may help to avoid memory-related side effects, suggest the researchers.


Other Penn researchers collaborating on this work are Charles F. Murchison, Xiao-Yan Zhang, Wei-Ping Zhang, Ming Ouyang, and Anee Lee. The research was supported in part by grants from the National Institutes of Health, the National Alliance for Research on Schizophrenia and Depression, and the Mental Retardation and Developmental Disabilities Research Center at the Children's Hospital of Philadelphia. The authors have no competing financial interest in this work.

Embargoed copies of the Cell paper can be obtained at:

PENN Medicine is a $2.5 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System (created in 1993 as the nation's first integrated academic health system).

Penn's School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #4 in the nation in U.S. News & World Report's most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.

Penn Health System consists of four hospitals (including its flagship Hospital of the University of Pennsylvania, consistently rated one of the nation's "Honor Roll" hospitals by U.S. News & World Report), a faculty practice plan, a primary-care provider network, three multispecialty satellite facilities, and home health care and hospice.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.